How A $37,000-A-Year Medicine Sets A Good Model For Drug Pricing
Shortly before his company won the right last week to sell a new drug for severe eczema, Dr. Len Schleifer made a brash promise.
He vowed to price the medicine “responsibly” and avoid the anger that high drug prices have stirred. “You’ll get to judge me and see how we do,” he told me.
To his credit, Schleifer appears to have delivered.
He vowed to price the medicine “responsibly” and avoid the anger that high drug prices have stirred. “You’ll get to judge me and see how we do,” he told me.
To his credit, Schleifer appears to have delivered.